Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?

Corzo P, Pros A, Martinez-Llorens J, Molina L, Ling SF, Balcells E.

Clin Rheumatol. 2018 Oct 27. doi: 10.1007/s10067-018-4342-5. [Epub ahead of print]

PMID:
30368639
2.

Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial.

Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Benet M, Borrell E, Celorrio N, Delgado A, Jané C, Marin A, Martín-Cantera C, Monteagudo M, Montellà N, Muñoz L, Ortega P, Rodríguez DA, Rodríguez-Roisin R, Simonet P, Torán-Monserrat P, Torrent-Pallicer J, Vall-Casas P, Vilaró J, Garcia-Aymerich J.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800063. doi: 10.1183/13993003.00063-2018. Print 2018 Oct.

3.

Nutritional Abnormalities And Muscle Dysfunction In Idiopathic Pulmonary Fibrosis.

Gea J, Bàdenes D, Balcells E.

Arch Bronconeumol. 2018 Nov;54(11):545-546. doi: 10.1016/j.arbres.2018.04.008. Epub 2018 Jun 19. English, Spanish. No abstract available.

4.

Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort.

Martínez-González C, Casanova C, de-Torres JP, Marín JM, de Lucas P, Fuster A, Cosío BG, Calle M, Peces-Barba G, Solanes I, Agüero R, Feu-Collado N, Alfageme I, Romero Plaza A, Balcells E, de Diego A, Marín Royo M, Moreno A, Llunell Casanovas A, Galdiz JB, Golpe R, Lacárcel Bautista C, Cabrera C, Marin A, Soriano JB, Lopez-Campos JL; CHAIN Study Investigators.

Chest. 2018 Aug;154(2):274-285. doi: 10.1016/j.chest.2018.02.007. Epub 2018 Feb 22.

PMID:
29476876
5.

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.

Casanova C, Celli BR, de-Torres JP, Martínez-Gonzalez C, Cosio BG, Pinto-Plata V, de Lucas-Ramos P, Divo M, Fuster A, Peces-Barba G, Calle-Rubio M, Solanes I, Aguero R, Feu-Collado N, Alfageme I, De Diego A, Romero A, Balcells E, Llunell A, Galdiz JB, Marin M, Moreno A, Cabrera C, Golpe R, Lacarcel C, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Marin JM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701162. doi: 10.1183/13993003.01162-2017. Print 2017 Nov.

PMID:
29167301
6.

Pulmonary eosinophilia associated to treatment with natalizumab.

Curto E, Munteis-Olivas E, Balcells E, Domínguez-Álvarez MM.

Ann Thorac Med. 2016 Jul-Sep;11(3):224-6. doi: 10.4103/1817-1737.185762.

7.

Validation of Walking Trails for the Urban Training™ of Chronic Obstructive Pulmonary Disease Patients.

Arbillaga-Etxarri A, Torrent-Pallicer J, Gimeno-Santos E, Barberan-Garcia A, Delgado A, Balcells E, Rodríguez DA, Vilaró J, Vall-Casas P, Irurtia A, Rodriguez-Roisin R, Garcia-Aymerich J; Urban Training™ Study Group.

PLoS One. 2016 Jan 14;11(1):e0146705. doi: 10.1371/journal.pone.0146705. eCollection 2016.

8.

Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD.

Ramon MA, Ferrer J, Gimeno-Santos E, Donaire-Gonzalez D, Rodríguez E, Balcells E, de Batlle J, Benet M, Guerra S, Sauleda J, Ferrer A, Farrero E, Gea J, Barberà JA, Agustí A, Rodriguez-Roisin R, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Respirology. 2016 Apr;21(3):476-82. doi: 10.1111/resp.12723. Epub 2015 Dec 30.

9.

Benefits of physical activity on COPD hospitalisation depend on intensity.

Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, de Batlle J, Ramon MA, Rodriguez E, Farrero E, Benet M, Guerra S, Sauleda J, Ferrer A, Ferrer J, Barberà JA, Rodriguez-Roisin R, Gea J, Agustí A, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2015 Nov;46(5):1281-9. doi: 10.1183/13993003.01699-2014. Epub 2015 Jul 23.

10.

[Interferon-gamma release assay in healthcare workers].

Hernández M, Balcells E.

Rev Chilena Infectol. 2014 Dec;31(6):766. doi: 10.4067/S0716-10182014000600025. Spanish. No abstract available.

11.

Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Solanes-García I, Agüero R, Feu-Collado N, Calle-Rubio M, Alfageme I, de Diego-Damia A, Irigaray R, Marín M, Balcells E, Llunell A, Galdiz JB, Golpe R, Lacarcel C, Cabrera C, Marin A, Soriano JB, Lopez-Campos JL, Soler-Cataluña JJ, de-Torres JP; COPD History Assessment in Spain (CHAIN) Cohort.

Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.

PMID:
25612228
12.

Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.

Balcells E, Gimeno-Santos E, de Batlle J, Ramon MA, Rodríguez E, Benet M, Farrero E, Ferrer A, Guerra S, Ferrer J, Sauleda J, Barberà JA, Agustí À, Rodriguez-Roisin R, Gea J, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

BMC Pulm Med. 2015 Jan 17;15:4. doi: 10.1186/1471-2466-15-4.

13.

[Sarcoidosis-lymphoma syndrome].

Giralt L, Sánchez-Font A, Sánchez-González B, Balcells E.

Med Clin (Barc). 2015 Sep 21;145(6):276-7. doi: 10.1016/j.medcli.2014.11.010. Epub 2015 Jan 8. Spanish. No abstract available.

PMID:
25579775
14.

[Adult pulmonary Langerhans' cell histiocytosis: approach to the reality of the Spanish population].

Castillo D, Martin-Arroyo I, Moreno A, Balcells E, Villar A, Vicens-Zygmunt V, Vendrell M, Belda S, Portillo K, Kettou D, Aparicio F, Molina-Molina M; en nombre del grupo CRAMPID.

Med Clin (Barc). 2014 Nov 18;143(10):433-9. doi: 10.1016/j.medcli.2013.11.039. Epub 2014 Apr 13. Spanish.

PMID:
24726261
15.

Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort.

de Torres JP, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Calle-Rubio M, Solanes-García I, Agüero Balbin R, de Diego-Damia A, Feu-Collado N, Alfageme Michavila I, Irigaray R, Balcells E, Llunell Casanovas A, Galdiz Iturri JB, Marín Royo M, Soler-Cataluña JJ, Lopez-Campos JL, Soriano JB, Casanova C; COPD History Assessment in Spain (CHAIN) Cohort*.

Chest. 2014 Jul;146(1):111-122. doi: 10.1378/chest.13-2246.

PMID:
24522636
16.

Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients.

Rodríguez E, Ferrer J, Zock JP, Serra I, Antó JM, de Batlle J, Kromhout H, Vermeulen R, Donaire-González D, Benet M, Balcells E, Monsó E, Gayete A, Garcia-Aymerich J; PAC-COPD Study Group.

PLoS One. 2014 Feb 6;9(2):e88426. doi: 10.1371/journal.pone.0088426. eCollection 2014.

17.

New GOLD classification: longitudinal data on group assignment.

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Calle-Rubio M, Solanes-García I, Agüero R, de Diego-Damia A, Feu-Collado N, Alfageme I, Irigaray R, Balcells E, Llunell A, Galdiz JB, Marín M, Soler-Cataluña JJ, Lopez-Campos JL, Soriano JB, de-Torres JP; COPD History Assessment In SpaiN (CHAIN) Cohort.

Respir Res. 2014 Jan 13;15:3. doi: 10.1186/1465-9921-15-3. Erratum in: Respir Res. 2014;15:140. Respir Res. 2014;15:140.

18.

Hospital admissions and exercise capacity decline in patients with COPD.

Ramon MA, Gimeno-Santos E, Ferrer J, Balcells E, Rodríguez E, de Batlle J, Gómez FP, Sauleda J, Ferrer A, Barberà JA, Agustí A, Gea J, Rodriguez-Roisin R, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2014 Apr;43(4):1018-27. doi: 10.1183/09031936.00088313. Epub 2014 Jan 3.

19.

Erratum: New GOLD classification: longitudinal data on group assignment.

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Calle-Rubio M, Solanes-García I, Agüero R, de Diego-Damia A, Feu-Collado N, Alfageme I, Irigaray R, Balcells E, Llunel A, Galdiz-Iturri JB, Marín M, Soler JJ, Lopez-Campos JL, Soriano JB, de-Torres JP; COPD History Assessment In SpaiN (CHAIN) cohort.

Respir Res. 2014 Dec 11;15:140. doi: 10.1186/s12931-014-0140-z. No abstract available.

20.

Physical activity in COPD patients: patterns and bouts.

Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, Rodríguez DA, Farrero E, de Batlle J, Benet M, Ferrer A, Barberà JA, Gea J, Rodriguez-Roisin R, Antó JM, Garcia-Aymerich J.

Eur Respir J. 2013 Oct;42(4):993-1002. doi: 10.1183/09031936.00101512. Epub 2012 Dec 20.

21.

The day hospital: analysis of results, costs and management of pneumology resources.

Cots F, Raventòs J, Ausín P, Chiarello P, Balcells E, Castells X, Gea J.

Arch Bronconeumol. 2013 Feb;49(2):54-62. doi: 10.1016/j.arbres.2012.09.007. Epub 2012 Nov 6. English, Spanish.

22.

Cured meat consumption increases risk of readmission in COPD patients.

de Batlle J, Mendez M, Romieu I, Balcells E, Benet M, Donaire-Gonzalez D, Ferrer JJ, Orozco-Levi M, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2012 Sep;40(3):555-60. Epub 2012 Mar 9.

23.

The first case of tinea faciei caused by Trichophyton mentagrophytes var. erinacei isolated in Chile.

Concha M, Nicklas C, Balcells E, Guzmán AM, Poggi H, León E, Fich F.

Int J Dermatol. 2012 Mar;51(3):283-5. doi: 10.1111/j.1365-4632.2011.04995.x.

PMID:
22348562
24.

[Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients].

Donaire-Gonzalez D, Gimeno-Santos E, Serra I, Roca J, Balcells E, Rodríguez E, Farrero E, Antó JM, Garcia-Aymerich J; en representación del PAC-COPD Study Group.

Arch Bronconeumol. 2011 Nov;47(11):552-60. doi: 10.1016/j.arbres.2011.07.002. Epub 2011 Oct 4. Spanish.

25.

Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD.

de Batlle J, Sauleda J, Balcells E, Gómez FP, Méndez M, Rodriguez E, Barreiro E, Ferrer JJ, Romieu I, Gea J, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

J Nutr Biochem. 2012 Jul;23(7):817-21. doi: 10.1016/j.jnutbio.2011.04.005. Epub 2011 Sep 1.

PMID:
21889886
26.

Soft drinks consumption, diet quality and BMI in a Mediterranean population.

Balcells E, Delgado-Noguera M, Pardo-Lozano R, Roig-González T, Renom A, González-Zobl G, Muñoz-Ortego J, Valiente-Hernández S, Pou-Chaubron M, Schröder H.

Public Health Nutr. 2011 May;14(5):778-84. doi: 10.1017/S1368980010002788. Epub 2010 Oct 19.

PMID:
20955643
27.

Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction.

Jorapur V, Lamas GA, Sadowski ZP, Reynolds HR, Carvalho AC, Buller CE, Rankin JM, Renkin J, Steg PG, White HD, Vozzi C, Balcells E, Ragosta M, Martin CE, Srinivas VS, Wharton Iii WW, Abramsky S, Mon AC, Kronsberg SS, Hochman JS.

World J Cardiol. 2010 Jan 26;2(1):13-8. doi: 10.4330/wjc.v2.i1.13.

28.

Factors affecting the relationship between psychological status and quality of life in COPD patients.

Balcells E, Gea J, Ferrer J, Serra I, Orozco-Levi M, de Batlle J, Rodriguez E, Benet M, Donaire-González D, Antó JM, Garcia-Aymerich J; PAC-COPD Study Group.

Health Qual Life Outcomes. 2010 Sep 27;8:108. doi: 10.1186/1477-7525-8-108.

29.

Dietary modulation of oxidative stress in chronic obstructive pulmonary disease patients.

de Batlle J, Barreiro E, Romieu I, Mendez M, Gómez FP, Balcells E, Ferrer J, Orozco-Levi M, Gea J, Antó JM, Garcia-Aymerich J.

Free Radic Res. 2010 Nov;44(11):1296-303. doi: 10.3109/10715762.2010.500667.

PMID:
20815775
30.

Sewing needles embedded in the cardiac interventricular septum and chest wall.

Mick SL, Abdullah I, Tchantchaleishvili V, Razo Vazquez AO, Gilfeather MS, Balcells E, Chen FY.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):709-10. doi: 10.1016/j.jtcvs.2010.07.042. No abstract available.

31.

Mass of intercostal muscles associates with risk of multiple exacerbations in COPD.

Güerri R, Gayete A, Balcells E, Ramirez-Sarmiento A, Vollmer I, Garcia-Aymerich J, Gea J, Orozco-Levi M.

Respir Med. 2010 Mar;104(3):378-88. doi: 10.1016/j.rmed.2009.10.015. Epub 2009 Nov 20.

32.

Dietary habits of firstly admitted Spanish COPD patients.

de Batlle J, Romieu I, Antó JM, Mendez M, Rodríguez E, Balcells E, Ferrer A, Gea J, Rodriguez-Roisin R, Garcia-Aymerich J; PAC-COPD Study Group.

Respir Med. 2009 Dec;103(12):1904-10. doi: 10.1016/j.rmed.2009.06.001. Epub 2009 Jun 28.

33.

Characteristics of patients admitted for the first time for COPD exacerbation.

Balcells E, Antó JM, Gea J, Gómez FP, Rodríguez E, Marin A, Ferrer A, de Batlle J, Farrero E, Benet M, Orozco-Levi M, Ferrer J, Agustí AG, Gáldiz JB, Belda J, Garcia-Aymerich J; PAC-COPD Study Group.

Respir Med. 2009 Sep;103(9):1293-302. doi: 10.1016/j.rmed.2009.04.001. Epub 2009 May 8.

34.

Physical activity and clinical and functional status in COPD.

Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí ÀG, Antó JM; Phenotype and Course of COPD (PAC-COPD) Study Group.

Chest. 2009 Jul;136(1):62-70. doi: 10.1378/chest.08-2532. Epub 2009 Mar 2.

PMID:
19255291
35.

[Prevalence of obstructive sleep apnea syndrome in patients with sick sinus syndrome].

Martí Almor J, Félez Flor M, Balcells E, Cladellas M, Broquetas J, Bruguera J.

Rev Esp Cardiol. 2006 Jan;59(1):28-32. Spanish.

36.

Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.

Micari A, Belcik TA, Balcells EA, Powers E, Wei K, Kaul S, Lindner JR.

Am J Cardiol. 2005 Nov 15;96(10):1410-5. Epub 2005 Sep 27.

PMID:
16275189
37.

Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve.

Balcells E, Powers ER, Lepper W, Belcik T, Wei K, Ragosta M, Samady H, Lindner JR.

J Am Coll Cardiol. 2003 Mar 5;41(5):827-33.

38.

[Fiber-optic bronchoscopic biopsy of bronchial smooth muscle. Efficacy of the technique in individuals with normal lung function and patients with COPD].

Curull V, Orozco-Levi M, Moyes D, Balcells E, Palacio J, Lloreta J, Broquetas JM.

Arch Bronconeumol. 2002 Nov;38(11):515-22. Spanish.

39.

Influence of deficient alpha1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults.

Miravitlles M, Vilà S, Torrella M, Balcells E, Rodríguez-Frías F, de la Roza C, Jardí R, Vidal R.

Respir Med. 2002 Mar;96(3):186-92.

40.

Intravascular adenosine: the endothelial mediators of its negative dromotropic effects.

Rubio R, Ceballos G, Balcells E.

Eur J Pharmacol. 1999 Apr 1;370(1):27-37.

PMID:
10323277
41.

Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations.

Balcells E, Meng QC, Johnson WH Jr, Oparil S, Dell'Italia LJ.

Am J Physiol. 1997 Oct;273(4 Pt 2):H1769-74.

PMID:
9362242
42.

Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs.

Dell'italia LJ, Balcells E, Meng QC, Su X, Schultz D, Bishop SP, Machida N, Straeter-Knowlen IM, Hankes GH, Dillon R, Cartee RE, Oparil S.

Am J Physiol. 1997 Aug;273(2 Pt 2):H961-70.

PMID:
9277516
43.

Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.

Dell'Italia LJ, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S.

J Clin Invest. 1997 Jul 15;100(2):253-8.

44.

[Benign asbestos pleural effusion. Report of a first series in Spain].

Ferrer J, Balcells E, Orriols R, Villarino MA, Drobnic Z, Morell F.

Med Clin (Barc). 1996 Oct 26;107(14):535-8. Spanish.

PMID:
8999213
45.

Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro.

Balcells E, Meng QC, Hageman GR, Palmer RW, Durand JN, Dell'Italia LJ.

Am J Physiol. 1996 Aug;271(2 Pt 2):H417-21.

PMID:
8770078
46.

Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation.

Dell'Italia LJ, Meng QC, Balcells E, Straeter-Knowlen IM, Hankes GH, Dillon R, Cartee RE, Orr R, Bishop SP, Oparil S, et al.

Am J Physiol. 1995 Dec;269(6 Pt 2):H2065-73.

PMID:
8594918
47.

Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue.

Meng QC, Balcells E, Dell'Italia L, Durand J, Oparil S.

Biochem Pharmacol. 1995 Oct 26;50(9):1445-50.

PMID:
7503795
48.

Adult onset of nemaline myopathy presenting as respiratory insufficiency.

Falgà-Tirado C, Pérez-Pemán P, Ordi-Ros J, Bofill JM, Balcells E.

Respiration. 1995;62(6):353-4.

PMID:
8552868
49.

[Pyogenic liver abscess and HIV].

de Otero J, Balcells E, Calvo F, Ribera E, Vicens JC, Martínez Vázquez JM.

Enferm Infecc Microbiol Clin. 1993 Dec;11(10):576-7. Spanish. No abstract available.

PMID:
8142518
50.

Supplemental Content

Loading ...
Support Center